▶ 調査レポート

世界のクローズドシステム転送装置(CSTD)市場2022年-2027年:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Closed System Transfer Devices (CSTD) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界のクローズドシステム転送装置(CSTD)市場2022年-2027年:成長・動向・新型コロナの影響・市場予測 / Closed System Transfer Devices (CSTD) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) / MRC2203A211資料のイメージです。• レポートコード:MRC2203A211
• 出版社/出版日:Mordor Intelligence / 2022年1月
• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥627,000 (USD4,750)▷ お問い合わせ
  Site Licence¥858,000 (USD6,500)▷ お問い合わせ
  Corporate License¥1,155,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社の本市場調査レポートでは、世界の閉鎖システム転送装置(CSTD)市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別(ニードルレスシステム、メンブレンツーメンブレンシステムへ)分析、閉鎖装置別(カラートゥカラー調整システム、ルーカーロックシステム、プッシュトゥターンシステム、クリックトゥロックシステム)分析、コンポーネント別(注射器安全装置、バイアルアクセス装置、バッグアクセス装置、その他)分析、技術別(区画化装置、ダイヤフラムベース装置、空気ろ過装置)分析、地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の閉鎖システム転送装置(CSTD)市場規模:種類別(ニードルレスシステム、メンブレンツーメンブレンシステムへ)
・世界の閉鎖システム転送装置(CSTD)市場規模:閉鎖装置別(カラートゥカラー調整システム、ルーカーロックシステム、プッシュトゥターンシステム、クリックトゥロックシステム)
・世界の閉鎖システム転送装置(CSTD)市場規模:コンポーネント別(注射器安全装置、バイアルアクセス装置、バッグアクセス装置、その他)
・世界の閉鎖システム転送装置(CSTD)市場規模:技術別(区画化装置、ダイヤフラムベース装置、空気ろ過装置)
・世界の閉鎖システム転送装置(CSTD)市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争状況(Allscripts Healthcare Solutions Inc.、Ascom Holding AG、Cerner CorporationBecton, Dickinson and Company、Caragen Ltd、Baxter International Inc.、…)
・市場機会・将来傾向

Limiting the exposure of hazardous drugs/chemicals is important due to the potential harm that might cause to the healthcare workers and patients in healthcare/clinical setups. Due to the increased incidence of hazardous drug exposures in many countries, the regulatory authorities have taken many initiatives to ensure the safety of patients and healthcare workers. Owing to the factors such as growing awareness regarding usage of closed system transfer devices and increased oncology drug approvals global closed system transfer devices (CSTD) market is expected to witness CAGR of 18% over the forecast period. Furthermore, increasing prevalence of cancer and technological advancements in the closed system transfer devices anticipated to boost the market growth. The High cost involved in the implementation of closed system transfer devices directly increases the cost of treatment/products. Furthermore, improper regulatory guidelines in developing and underdeveloped countries may hamper market growth over the forecast period. However, developments in CSTD technologies making devices more user-friendly and safer than the older devices.

Key Market Trends

Membrane to Membrane Transfer Devices Anticipated to Grow at Significant Rates

Membrane to membrane transfer devices use the double membrane system between the vial and syringe further helps to isolate the medication. The advantages such as ease of use, low risk of contamination and double-membrane systems ensure the safety anticipated to increase the usage of the membrane to membrane transfer devices over the forecast period. Needleless system segment is anticipated to grow at notable rates owing to the advantages such as needle-free transfer of the medication, new product launches and safety. For instance, in January 2018, Baxter International has launched Yukon Medical, LLC’s Airsure closed system transfer device in the United States to prevent contaminants to enter into an IV medication delivery system.

Moreover, the growing incidence of cancer cases and awareness regarding the usage of closed system transfer devices anticipated to fuel the market growth.

North America Expected to have Significant Market Share

North America is expected to have a significant market share in closed system transfer devices market. The growth is attributed to initiatives taken by the U.S. Food and Drug Administration and other regulatory bodies in North America to ensure patient safety coupled with the increasing number of oncology drug approvals in the region. The Asia Pacific region is projected to have the notable growth rate owing to the factors such as the increase in cancer research, growing prevalence of cancer in developing and underdeveloped countries of the region. Furthermore, the usage of the closed system transfer devices to combat the hazardous drugs in the region and continuous efforts by the public and private organizations anticipated to boost the regional growth.

Competitive Landscape

Global transfer membrane market is moderately consolidated and competitive. Market players are focusing on new product launches, product innovations and geographical expansion. The key market players operating in the market include Becton, Dickinson and Company, ICU Medical, Inc., Caragen Ltd., Baxter International Inc. and B. Braun Melsungen AG among others

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Cancer and increasing Oncology Drug Approvals
4.2.2 Advancements in Technologies and Improving Regulatory Guidelines
4.3 Market Restraints
4.3.1 High Cost for Closed System Transfer Device Implementation
4.3.2 Lack of Proper Regulatory Guidelines In Many of the Countries
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Needless Systems
5.1.2 Membrane to Membrane Systems
5.2 By Closing Mechanism
5.2.1 Colour to Colour Alignment Systems
5.2.2 Lueker Lock Systems
5.2.3 Push to Turn systems
5.2.4 Click to Lock Systems
5.3 By Component
5.3.1 Syringe Safety Devices
5.3.2 Vial Access Devices
5.3.3 Bag Access Devices
5.3.4 Others
5.4 By Technology
5.4.1 Compartmentalize Devices
5.4.2 Diaphragm Based Devices
5.4.3 Air Filtration Devices
5.5 By End-Use
5.5.1 Hospitals
5.5.2 Oncology Clinics and Oncology Centers
5.5.3 Others
5.6 Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 Germany
5.6.2.2 United Kingdom
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Middle-East and Africa
5.6.4.1 GCC
5.6.4.2 South Africa
5.6.4.3 Rest of Middle-East and Africa
5.6.5 South America
5.6.5.1 Brazil
5.6.5.2 Argentina
5.6.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Caragen Ltd
6.1.3 Baxter International Inc.
6.1.4 B. Braun Melsungen AG
6.1.5 ICU Medical, Inc.
6.1.6 Corvida Medical
6.1.7 JMS CO., LTD.
6.1.8 Equashield, LLC
6.1.9 Yukon Medical, LLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS